Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) Sees Significant Decline in Short Interest

Harrow Health, Inc. 8.625% Senior Notes due 2026 (NASDAQ:HROWL) was the recipient of a large decrease in short interest during the month of December. As of December 15th, there was short interest totalling 300 shares, a decrease of 62.5% from the November 30th total of 800 shares. Based on an average daily volume of 3,800 shares, the days-to-cover ratio is currently 0.1 days.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Stock Performance

NASDAQ HROWL traded down $0.08 during trading on Thursday, hitting $25.31. 581 shares of the company’s stock traded hands, compared to its average volume of 5,367. The stock has a fifty day moving average of $25.32 and a two-hundred day moving average of $25.35. Harrow Health, Inc. 8.625% Senior Notes due 2026 has a 12-month low of $23.71 and a 12-month high of $25.73.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Announces Dividend

The company also recently announced a quarterly dividend, which was paid on Thursday, October 31st. Investors of record on Tuesday, October 15th were paid a $0.5391 dividend. This represents a $2.16 annualized dividend and a dividend yield of 8.52%. The ex-dividend date was Tuesday, October 15th.

Harrow Health, Inc. 8.625% Senior Notes due 2026 Company Profile

harrow health, inc., together with its subsidiaries, develops, produces, and sells medications for unmet needs primarily in the united states. the company primarily provides ophthalmology based formulations to physicians and patients; and sterile and non-sterile compounded medications. it also develops and commercializes therapeutics for treating ocular surface diseases; and non-intravenous sedation and anesthesia therapeutics for human medical procedures in hospital, outpatient, and in-office settings.